These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 23201823)
21. Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules. Ostrin EJ; Bantis LE; Wilson DO; Patel N; Wang R; Kundnani D; Adams-Haduch J; Dennison JB; Fahrmann JF; Chiu HT; Gazdar A; Feng Z; Yuan JM; Hanash SM J Thorac Oncol; 2021 Feb; 16(2):228-236. PubMed ID: 33137463 [TBL] [Abstract][Full Text] [Related]
22. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules. Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers to help guide management of patients with pulmonary nodules. Patz EF; Campa MJ; Gottlin EB; Trotter PR; Herndon JE; Kafader D; Grant RP; Eisenberg M Am J Respir Crit Care Med; 2013 Aug; 188(4):461-5. PubMed ID: 23306547 [TBL] [Abstract][Full Text] [Related]
24. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness. Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403 [TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease-endemic region. Henz Concatto N; Watte G; Marchiori E; Irion K; Felicetti JC; Camargo JJ; Hochhegger B Eur Radiol; 2016 Sep; 26(9):2915-20. PubMed ID: 26638164 [TBL] [Abstract][Full Text] [Related]
27. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules. Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
29. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782 [TBL] [Abstract][Full Text] [Related]
30. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea. Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219 [TBL] [Abstract][Full Text] [Related]
31. Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study. Li Y; Xie F; Zheng Q; Zhang Y; Li W; Xu M; He Q; Li Y; Sun J Lung Cancer; 2024 Sep; 195():107930. PubMed ID: 39146624 [TBL] [Abstract][Full Text] [Related]
32. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules. Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of Multi-slice Spiral CT and Rapid On-site Evaluation in Diagnosis of Pulmonary Nodules. Liu H; Wang H; Xiong C; Hu B Altern Ther Health Med; 2024 Jul; 30(7):222-227. PubMed ID: 37971446 [TBL] [Abstract][Full Text] [Related]
34. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. Revel MP; Merlin A; Peyrard S; Triki R; Couchon S; Chatellier G; Frija G AJR Am J Roentgenol; 2006 Jul; 187(1):135-42. PubMed ID: 16794167 [TBL] [Abstract][Full Text] [Related]
35. Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules. Kammer MN; Lakhani DA; Balar AB; Antic SL; Kussrow AK; Webster RL; Mahapatra S; Barad U; Shah C; Atwater T; Diergaarde B; Qian J; Kaizer A; New M; Hirsch E; Feser WJ; Strong J; Rioth M; Miller YE; Balagurunathan Y; Rowe DJ; Helmey S; Chen SC; Bauza J; Deppen SA; Sandler K; Maldonado F; Spira A; Billatos E; Schabath MB; Gillies RJ; Wilson DO; Walker RC; Landman B; Chen H; Grogan EL; Barón AE; Bornhop DJ; Massion PP Am J Respir Crit Care Med; 2021 Dec; 204(11):1306-1316. PubMed ID: 34464235 [No Abstract] [Full Text] [Related]
36. The frequency and significance of radiologically detected indeterminate pulmonary nodules in patients with colorectal cancer. Varol Y; Varol U; Karaca B; Karabulut B; Sezgin C; Uslu R Med Princ Pract; 2012; 21(5):457-61. PubMed ID: 22572176 [TBL] [Abstract][Full Text] [Related]
37. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544 [TBL] [Abstract][Full Text] [Related]
38. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules. Szpechcinski A; Rudzinski P; Kupis W; Langfort R; Orlowski T; Chorostowska-Wynimko J Cancer Lett; 2016 May; 374(2):202-7. PubMed ID: 26854716 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma. Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586 [TBL] [Abstract][Full Text] [Related]
40. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]